SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: Scott H. Davis who wrote (2558)4/28/1999 6:36:00 PM
From: sds  Read Replies (2) | Respond to of 4676
 
In re: (I wonder as more data comes in, if the FDA will re-consider Vitravene as a first line therapy)

I doubt it. By the time enough data comes in, the 2nd-generation compound might be close to "prime time". That said, who knows?

Either way, its too small of a market to really matter.

sds